Lowest Price Guaranteed
Slides
248
Last Updated
June 2025
View Count
5565
The global miRNA tools and services market, valued at USD 519.71 million in 2024, is projected to reach USD 629.69 million in 2025 and USD 2,940.53 million by 2035, representing a CAGR of 16.7% during the forecast period.
 |
To learn more about this report, request a free sample copy
miRNA tools and services industry is rapidly gaining momentum driven by the increasing demand for advanced therapeutic and diagnostic technologies to treat patients. These tools and services cover next generation sequencing, microarray, quantification and bioinformatics to explore miRNA role in biological processes, diseases, and identification of targeted genes. miRNA stands for small non-coding RNA molecules that play a significant role in regulating gene expression during post-transcriptional level and pathology of diseases. Furthermore, miRNA can be used as biomarkers for early disease detection and personalized drug development.
Notably, miRNA has become a cornerstone for the pharmaceutical industry to develop advanced drug formulation based on miRNA for targeting a wide range of diseases, including viral diseases, genetic disorders and cancer. With expanding research on advanced RNA based drug formulation, there is a surge in the demand for miRNA tools and services that further catered the attention of industrial players.
It is worth mentioning here that several industrial players are currently undertaking strategic initiatives to develop more innovative tools and services that aid in detailed analysis of miRNA to explore its usage across wide range of applications. For instance, in February 2025, Roche revealed its proprietary, sequencing by expansion (SBX) technology (marked as a new category of next-generation sequencing). This newly launched technology combines sensor modules to offer high throughput and ultra-rapid sequencing to gain deep insight into miRNA, cell biology, genomics and genetics. Given by the increasing research on miRNA and demand for next generation tools / services, we believe that miRNA tools and services market will continue to grow at a steady pace during the forecast period.
The market report provides comprehensive information on industrial players who are currently active across various segments of the industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | USD 629.69 Million | |
| Market Size 2035 | USD 2,940.53 Million | |
| CAGR (Till 2035) | 16.7% | |
| Type of Product / Service |
|
|
| Type of Technology |
|
|
| Application Area |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the miRNA tools and services market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global miRNA tools and services market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product (research tools (kits, reagents, and others) and services (miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others)), type of technology (miRNA extraction tools, qRT-PCR, next generation sequencing, microarray, functional analysis tools, and others), application area (research, diagnostics, therapeutics, and agriculture), end user (academic and research institutions, biotechnology companies, pharmaceutical companies and contract research organizations), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of product, the global market is segmented into research tools (kits, reagents, and others) and services (miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others). According to the miRNA tools and services market report, presently research tools account for the largest share (72%) of the market. Research tools, such as kits and reagents are widely used for the analysis and extraction of miRNA. Furthermore, miRNA research tools are also adopted on a large scale for conducting experimental validation studies.
However, in the long run, services segment is expected to grow at a substantial CAGR over the forecast period. This can be attributed to the growing shift towards third party sequencing technology services providers for cost-cutting and faster analysis reflects a dynamic growth of this segment during the forecast period.
The global market is further categorized across different types of technology, such as miRNA extraction tools, qRT-PCR, next generation sequencing, microarray, functional analysis tools, and others. According to our miRNA tools and services market analysis, presently qRT-PCR occupies the highest share (25%) of the market. This can be attributed to the fact that qRT-PCR is widely used for miRNA analysis by researchers as it offers high accuracy, sensitivity and real-time data for large scale studies. However, it is worth mentioning that next generation sequencing segment is likely to grow at a higher CAGR during the forecast period. Next generation sequencing offers high throughput sequencing with utmost accuracy which is crucial for detailed study of miRNA profiling.
This segment highlights the distribution of global market across different application areas, such as research, diagnostics, therapeutics, and agriculture. Presently, the research segment is dominating the market for miRNA tools and services, and the trend is likely to remain unchanged during the forecast period. This dominance is due to the expanding research on genomics to understand the disease mechanism and role of miRNA in biological processes and gene expression that has contributed to the heightened demand for miRNA tools and services. Driven by the ongoing demand in research area, this segment is expected to grow at a higher CAGR during the forecast period.
Based on the end user, the global market is bifurcated into academic and research institutions, biotechnology companies, pharmaceutical companies and contract research organizations. According to miRNA tools and services market size, presently academic research and institutes segment is dominating the market by holding nearly 35% share of the market. This is potentially due to the fact that a large number of academic research institutes, universities and research centers are engaged in the genomic studies to uncover the underlying mechanism of diseases and developing drugs. Additionally, the researchers are also adopting advanced sequencing technologies for determining gene regulation which further created a massive demand for miRNA tools.
However, the contract research organizations segment is anticipated to register a higher CAGR during the forecast period. This can be attributed to the rising trend of outsourcing miRNA research and genomics tools to reduce cost of research and accelerate the project time. Furthermore, contract research organizations provide comprehensive tools for validation, profiling and data analytics.
The global market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to market analysis, North America is dominating the market for miRNA tools and services by holding 42% share. This dominance is due to the increasing research on genomics in this field and rising demand for personalized therapies.
However, in Asia-Pacific, the market for miRNA tools and services is expected to grow dynamically at a higher CAGR during the forecast period. This is likely to be the result of growing government initiatives to support genomic research and demand advanced tools for understanding the disease mechanism.
The “miRNA Tools and Services Market Analysis Report: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for miRNA tools and services provider industrial players. The market research report lays emphasis on the miRNA tools and services solutions that are being developed. Key takeaways of the market report are briefly discussed below.
Currently, the market landscape seems moderately competitive, witnessing the presence of several well-established and new entrants. Majority of the industrial players, such as Agilent Technologies, Merck and Roche are focusing on technological innovations and services expansion to meet the growing demand for miRNA tools and services. For instance, in October 2024, Agilent Technologies announced the release of latest next-generation Agilent InfinityLab LC Series portfolio that includes, the 1260 Infinity III LC, 1260 Infinity III LC systems, and 1290 Infinity III LC, along with biocompatible version and built-in system assistance abilities. This newly launched technology automates the sample mix-ups process, predictive feedback for seamless sampling experience. As more market players continue to drive technological innovations, this market is expected to remain competitive during the forecast period.
miRNA tools and services industry are driven by the expanding research on genomics to understand the underlying mechanism of diseases. It is worth mentioning that researchers are consistently focusing on unveiling the role of miRNA in biological processes which has further fueled the demand for miRNA tools and services solutions. Additionally, the growing shift towards personalized therapeutics and disease diagnosis which further anticipated to be a key driver for the market.
Despite growing demand, there are several factors that are impeding market growth. Some of the notable challenges in the miRNA tools and services market are lack of standardization and complex data analysis. Notably, regulatory agencies offer limited standardized protocol for miRNA tools manufacturing and approval which create significant challenge for market players in defining robustness of tools for predicting research outcomes. Furthermore, complex data analysis process may create challenges in harmonizing results due to the involvement of large datasets and intricated miRNA regulatory networks.
Some of the notable miRNA tools and services market growth factors include technological innovations and integration of miRNA tools with multi-omics. Notably, the combining of miRNA tools with multi-omics offers lucrative opportunities to market players to unfold the multiple omics layers, such as proteomics, and spatial genomics and transcriptomics. Furthermore, the integration of miRNA tools and multi-omics increases the capability of interpreting complex biological networks for comprehensive understanding of miRNA expression patters functions. In addition, the growing demand for miRNA tools to explore wide range of applications, such as disease diagnosis, biomarker identification and genomic research has further contributed to the unprecedented growth of this industry in the future.
Currently, the global miRNA tools and services market is valued at USD 629.69 million and is expected to reach USD 2,940.53 million by 2035. Driven by the growing demand for miRNA tools for detailed research on genomics, this market is anticipated to grow at a CAGR of 16.7% during the forecast period. It is worth mentioning that several industrial players are entering into collaborations and partnerships to accelerate technological innovations. For instance, in October 2024, QIAGEN Digital Insights (the bioinformatics business of QIAGEN) expanded its strategic partnership with Neo4j®. Under this collaboration, the Neo4j® graph database and graph data science capabilities will be integrated with QIAGEN biomedical knowledge bade product line aiming to reveal hidden relationships and patterns in biomedical data. This collaboration offers new insights to drug repurpose, drug discovery and translation research.
Examples of key players engaged in this domain (which have also been captured in this report) include Abcam, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, GeneCopoeia, Illumina, Merck, New England BioLabs, Norgen Biotek, Promega, PerkinElmer, Qiagen, Roche, Thermo Fisher Scientific and Takara Bio. This market report includes an easily searchable excel database of all the companies focusing on the development of miRNA tools and services solutions.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of miRNA tools and services. We have outlined some of these recent initiatives below.